药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Clonitazene
Ribociclib
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Ribociclib.
Clonitazene
Ivabradine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Ivabradine.
Clonitazene
Lumefantrine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Lumefantrine.
Clonitazene
Artemether
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Artemether.
Clonitazene
Asenapine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Asenapine.
Clonitazene
Iloperidone
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Iloperidone.
Clonitazene
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Tetrabenazine.
Clonitazene
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Zuclopenthixol.
Clonitazene
Berotralstat
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Berotralstat.
Clonitazene
Encorafenib
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Encorafenib.
Clonitazene
Ivosidenib
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Ivosidenib.
Clonitazene
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Dexchlorpheniramine.
Clonitazene
Sultopride
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Sultopride.
Clonitazene
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Sitafloxacin.
Clonitazene
Oxatomide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Oxatomide.
Clonitazene
Abexinostat
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Abexinostat.
Clonitazene
Mizolastine
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Mizolastine.
Clonitazene
Ricolinostat
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Ricolinostat.
Clonitazene
CUDC-101
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with CUDC-101.
Clonitazene
Entinostat
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Entinostat.